학술논문

Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer
Document Type
Article
Source
In: Scientific Reports. (Scientific Reports, December 2022, 12(1))
Subject
Language
English
ISSN
20452322